Phases of growth for hyper-growth companies w/ Rodrigo Hutt of Viome (EP27)

Joining us on this episode is Rodrigo Hutt, VP & General Manager @ Viome Life Sciences a D2C biotech company that is revolutionizing personalized health care ($169.5M in total funding). He's had a diverse career path across multiple industries including biopharma, entrepreneurship, e-commerce, to now health tech innovation. He shares with the current challenges around health prevention in the U.S., Viome’s approach to education-based marketing, and how he thinks about phases of growth startups go through. More highlights include: The importance of maintaining an entrepreneurial mindset and executing with speed. Cultural values for high-performing teams. Breaking down Viome's customer segmentations. How he thinks about prioritization in phases for growth. What his priortization scoring model is (hint: impact to cost to effort). Follow us and our guests: Rodrigo Hutt on LinkedIn   / rodrigohutt   and X   / rodrigohutt   Nima Gardideh on LinkedIn   / nimagardideh   and X   / ngardideh   Pearmill on LinkedIn   / admin   and X   / _pearmill  

Rick Klau, Google: OKRs (Objectives and Key Results) - How Hyper-Growth Startups Stay Focused
▶︎

Rick Klau, Google: OKRs (Objectives and Key Results) - How Hyper-Growth Startups Stay Focused

Michael Stoppelman: Managing at a Hyper-Growth Startup
▶︎

Michael Stoppelman: Managing at a Hyper-Growth Startup

Why Your Vulnerability Backlog Will Never Get Fixed (And How AI Changes That)
▶︎

Why Your Vulnerability Backlog Will Never Get Fixed (And How AI Changes That)

Conan O’Brien Delivers the Commencement Address | Harvard Commencement 2026
▶︎

Conan O’Brien Delivers the Commencement Address | Harvard Commencement 2026

The Fintech Marketing Playbook for Complex Products, Long Sales Cycles, and Messy Attribution
▶︎

The Fintech Marketing Playbook for Complex Products, Long Sales Cycles, and Messy Attribution

The French Do Not Care About Work
▶︎

The French Do Not Care About Work

From IT support to co-founding BorrowMyDoggy: Les Cochrane on his road to becoming a CTO
▶︎

From IT support to co-founding BorrowMyDoggy: Les Cochrane on his road to becoming a CTO

Value Props: Create a Product People Will Actually Buy
▶︎

Value Props: Create a Product People Will Actually Buy

Building an SEO strategy with Ethan Smith (EP23)
▶︎

Building an SEO strategy with Ethan Smith (EP23)

🩸 Phlebotomy Technician Practice Quiz – with Nurse Eunice! 🎯
▶︎

🩸 Phlebotomy Technician Practice Quiz – with Nurse Eunice! 🎯

Carbohydrates - Aitor Viribay Energy Series pt 3
▶︎

Carbohydrates - Aitor Viribay Energy Series pt 3

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

How to Build Endurance | Huberman Lab Essentials
▶︎

How to Build Endurance | Huberman Lab Essentials

How Ghost Shops Triggered China’s Biggest Food Scandal | AB Explained
▶︎

How Ghost Shops Triggered China’s Biggest Food Scandal | AB Explained

Webinar The Art and Science of Ad Creative Tests on Meta
▶︎

Webinar The Art and Science of Ad Creative Tests on Meta

Magnus Invents A New Opening So OUTRAGEOUS, You'll Question EVERY Chess Principle!
▶︎

Magnus Invents A New Opening So OUTRAGEOUS, You'll Question EVERY Chess Principle!

PASS Your Phlebotomy Exam! 💉 Must-Know Terms + Practice Questions
▶︎

PASS Your Phlebotomy Exam! 💉 Must-Know Terms + Practice Questions

Simon Sinek's Advice Will Leave You SPEECHLESS 2.0 (MUST WATCH)
▶︎

Simon Sinek's Advice Will Leave You SPEECHLESS 2.0 (MUST WATCH)

Anthropic Files $965B IPO, OpenAI’s 1B MAUs, and Trump’s AI Order Rejects Heavy Regulation | EP #262
▶︎

Anthropic Files $965B IPO, OpenAI’s 1B MAUs, and Trump’s AI Order Rejects Heavy Regulation | EP #262

Clara Mattei: capitalism is not natural - it’s enforced
▶︎

Clara Mattei: capitalism is not natural - it’s enforced